Medicine and Dentistry
Abdominal Cancer
26%
Adenocarcinoma
7%
Adjuvant Therapy
10%
Adrenal Cortex Carcinoma
15%
Blood Transfusion
5%
Cancer
24%
Cancer Surgery
6%
Cholangiocarcinoma
21%
Colorectal Carcinoma
6%
Connective Tissue Cancer
17%
Disease Free Survival
6%
Disease Specific Survival
6%
Diseases
20%
Distal Pancreatectomy
5%
Gallbladder Cancer
13%
Hazard Ratio
13%
Hepatectomy
10%
Liver Metastasis
11%
Long Term Survival
9%
Lymph Node
21%
Lymph Node Metastasis
12%
Lymphovascular Invasion
5%
Malignant Neoplasm
14%
Melanoma
10%
Merkel Cell Carcinoma
6%
Metastatic Carcinoma
9%
Neoplasm
45%
Neuroendocrine Tumor
17%
Neutrophil
5%
Odds Ratio
8%
Overall Survival
45%
Pancreas Adenocarcinoma
10%
Pancreas Cancer
8%
Pancreas Islet Cell Tumor
26%
Pancreatectomy
7%
Pancreaticoduodenectomy
13%
Postoperative Complication
8%
Radiation Therapy
9%
Recurrence Free Survival
18%
Recurrent Disease
34%
Retroperitoneal Lymph Node Dissection
8%
Retroperitoneal Sarcoma
6%
Soft Tissue Sarcoma
11%
Stomach Adenocarcinoma
18%
Surgeon
7%
Surgery
100%
Surgical Margin
6%
Keyphrases
5-year Survival
7%
Adjuvant Therapy
10%
Adrenocortical Carcinoma
15%
Biliary Malignancy
17%
Confidence Interval
13%
Curative Intent
6%
Curative Resection
25%
Disease-free Survival
6%
Disease-specific Survival
6%
Early Recurrence
6%
Gallbladder Cancer
14%
Gastric Adenocarcinoma
17%
Gastric Cancer
24%
Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
6%
Hazard Ratio
15%
Hilar Cholangiocarcinoma
8%
Long-term Survival
9%
Lymph Node
7%
Lymph Node Metastasis
15%
Lymph Node Ratio
7%
Melanoma
11%
Merkel Cell Carcinoma
6%
Multi-institutional
9%
Multi-institutional Analysis
10%
Multi-institutional Study
11%
Multivariable
6%
Neuroendocrine Tumor
12%
Neuroendocrine Tumor Liver Metastases
11%
Nomogram
8%
Non-associated
6%
Odds Ratio
7%
Overall Survival
38%
Pancreas
6%
Pancreatectomy
7%
Pancreatic Cancer
12%
Pancreatic Ductal Adenocarcinoma
14%
Pancreatic Neuroendocrine Tumors (pNETs)
23%
Pancreaticoduodenectomy
12%
Postoperative Complications
6%
Recurrence-free Survival
20%
Resection
50%
Retroperitoneal Sarcoma
6%
Risk Factors
6%
Sarcoma
17%
Soft Tissue Sarcoma
6%
Surgical Resection
9%
Tumor
21%
Tumor Research
9%
Tumor Size
8%
United States
12%